ATM Reading Tools
How to cite item
mFOLFOXIRI with or without bevacizumab for conversion therapy of
RAS/BRAF/PIK3CA
mutant unresectable colorectal liver metastases: the FORBES non-randomized phase II trial
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{ATM}{89891}, author = {Shen, C., Hu, H., Cai, Y., Ling, J., Zhang, J., Wu, Z., Xie, X., Huang, M., Wang, H., Kang, L., Lan, P., Wu, X., Liu, G., Wan, Y., Zhou, Z., Huang, Y., Li, F., Wang, H., Ma, T., Luo, S., Cai, Y., Shi, L., Deng, Y.}, title = {mFOLFOXIRI with or without bevacizumab for conversion therapy of <em>RAS/BRAF/PIK3CA</em> mutant unresectable colorectal liver metastases: the FORBES non-randomized phase II trial}, journal = {Annals of Translational Medicine}, volume = {10}, number = {4}, year = {2022}, url = {https://atm.amegroups.org/article/view/89891} }